Protocol Review Sample Clauses
Protocol Review. Authorizing Physician will review the Agreement and the services provided under the Agreement on an annual basis. Authorizing Physician must receive a status report on the individual including any problems or complications encountered at least once each year.
Protocol Review. Authorizing Practitioner will review the services provided under the Agreement on an annual basis.
Protocol Review. Pharmacist must review this Agreement on an annual basis and must document this review.4
Protocol Review. Supervising Physician will review the services provided under the Agreement an annual basis.
Protocol Review. The parties agree that before either begins a clinical trial of a Product, whether conducted by or on behalf of such party, it will give the other party the opportunity to review the protocol for such trial, along with the opportunity to provide comments. The reviewing party shall have fourteen (14) days to complete such review. Notwithstanding any such consultation, the party conducting such clinical trial shall maintain full and sole responsibility regarding any such study protocol.
Protocol Review. Authorizing Physician will review the services provided under the Agreement at least once every two (2) years.
Protocol Review. This assessment protocol and agreement form will be reviewed annually by the NPQ Steering Group and approved by the NPQ Strategic Board. The next review of this NPQ Protocol is scheduled for July 2021.
Protocol Review. 14 Authorizing Physician must review and revise, if necessary, the services provided under this Agreement on an annual basis.
Protocol Review. 9.1. This Protocol will be reviewed annually or when deemed necessary by CSSIW or CRR Wales. Xxxxxx Xxxx Xxxxxxx Xxxxx Date Date All responsibility for enforcement in relation to fire safety has now transferred to the Fire and Rescue Authority (with the exception of childminders), from October 2006. However CSSIW has an overall duty under the Care Standards Act 2000 to protect vulnerable people through the regulations and national minimum standards. Information from the checklist below will be requested from the provider through the Self Assessment Form (SAF) which providers will be expected to return prior to an inspection in order to meet with regulatory requirements. In addition as part of our proportionate approach to inspection, inspectors will sample check a number of risk assessments, logs, plans on their inspection visit. The items below are general areas of evident concern that may act as ‘triggers’ for liaison with the local Fire and Rescue Service Fire Safety Officer (refer to Guidance Notes, P./iii). This is not an exhaustive list and as an organisation CSSIW has a duty to ensure that service users are safeguarded in relation to fitness of premises. Therefore, where inspectors come across additional issues of concern these too will be raised with colleagues in the Fire and Rescue Service where appropriate. Negative answers should therefore act as a prompt for such liaison.
Protocol Review. A single IRB will be utilized for the Study. Each Clinical Research Site will enter into a reliance agreement with the single IRB. In addition to the Protocol, all associated documents, including informational documents and advertisements, must be reviewed and approved by the single IRB before starting the research at each Clinical Research Site. The research will be done in strict accordance with the Protocol and no changes in a finalized Protocol will be made unless mutually agreed upon, in writing, by the Parties. Research will not commence or will continue unchanged (if already in progress) until each change to a Protocol, including those required by either the FDA or the IRB, has been integrated in a way acceptable to the Parties, submitted to the FDA (if applicable) and approved by the single IRB.